Five directors resign from Quince Therapeutics board effective immediately

Quince Therapeutics, Inc.

Directors Rajiv Patni, Luca Benatti, Margi McLoughlin, Una Ryan, and June Bray resigned on Jan 30, 2026.
Resignations were not due to any disagreement with the company on operations, policies, or practices.
CEO Dirk Thye remains as the sole executive officer; no replacements announced.
Company continues under current management; board size reduced from six to one.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.